FDG PET/CT features of ovarian metastasis

被引:9
|
作者
Kitajima, K. [1 ]
Suzuki, K.
Senda, M. [2 ]
Kita, M. [3 ]
Onishi, Y. [4 ]
Maeda, T. [4 ]
Yoshikawa, T. [4 ]
Ohno, Y. [4 ]
Sugimura, K. [4 ]
机构
[1] Inst Biomed Res & Innovat, Dept PET Diag, Chuo Ku, Kobe, Hyogo 6500047, Japan
[2] Inst Biomed Res & Innovat, Dept Mol Imaging, Kobe, Hyogo 6500047, Japan
[3] Kobe City Med Ctr Gen Hosp, Dept Obstet & Gynecol, Kobe, Hyogo, Japan
[4] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 657, Japan
关键词
ADNEXAL MASSES; CARCINOMA; TUMORS; CT;
D O I
10.1016/j.crad.2010.09.018
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
AIM: To assess the characteristics of [(18)F]-fluoro-2-deoxy-D-glucose (FOG) uptake in cases of ovarian metastasis using positron-emission tomography/computed tomography (PET/CT). MATERIALS AND METHODS: Twelve patients with 16 ovarian metastases arising from colon cancer (n = 6), breast cancer (n = 4), gastric cancer (n = 3), and pancreatic cancer (n = 3) who underwent FDG-PET/CT examination were included in this study. The effect of lesion size and morphological pattern (predominantly solid or cystic) on FDG uptake was evaluated using the quantitative standardized uptake value (SUV). RESULTS: The mean maximum SUV for the 16 lesions was 4.6 +/- 2.4 (range 1.8 similar to 9.9). The Pearson correlation coefficient test showed no significant correlation between maximum SUV and lesion size (r = 0.21, p = 0.42). The maximum SUV of solid (n = 5) and cystic (n = 11) lesions was 5.5 +/- 2.7 and 4.3 +/- 2.2, respectively, and the difference was not significant (p = 0.43). Breast cancer showed the highest maximum SUV (6.4 +/- 3.6), followed by colon cancer (5.3 +/- 1.4), gastric cancer (3.3 +/- 0.5), and pancreatic cancer (2.2 +/- 0.6). CONCLUSION: Ovarian metastases show a variable maximum SUV with mild to intense FDG uptake. (C) 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:264 / 268
页数:5
相关论文
共 50 条
  • [1] FDG PET/CT Findings in a Patient With Ovarian Metastasis of Pheochromocytoma
    Jiang, Yuanyuan
    Hou, Guozhu
    Cheng, Xin
    Zhu, Zhaohui
    Cheng, Wuying
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (11) : 931 - 932
  • [2] Ovarian Metastasis as Initial Presentation of Pancreatic Carcinoma on FDG PET/CT
    Hou, Guozhu
    Jiang, Yuanyuan
    Li, Fang
    Cheng, Xin
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (04) : 306 - 307
  • [3] Solitary Cerebellar Metastasis of Ovarian Cancer Detected by FDG PET/CT
    Hou, Guozhu
    Jiang, Yuanyuan
    Cheng, Xin
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (03) : 230 - 231
  • [4] Recurrent Ovarian Carcinoma Presenting as a Solitary Sternal Metastasis on FDG PET/CT
    Ho, Linh
    Kaushik, Aarti
    Zhang, Weifang
    Wassef, Heidi
    CLINICAL NUCLEAR MEDICINE, 2011, 36 (08) : 733 - 734
  • [5] Unilateral ovarian metastasis from gastric mucinous adenocarcinoma visualized on FDG PET/CT
    Tamam, M. O.
    Mulazimoglu, M.
    Kamali, G.
    Eker, O.
    Ozpacaci, T.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 : 1 - 3
  • [6] Recurrent Ovarian Cancer Presenting as a Solitary Chest Wall Metastasis Revealed by FDG PET/CT
    Shen, Guohua
    Kuang, Anren
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (04) : 365 - 366
  • [7] 18F-FDG PET-CT Findings in Pancreatic Adenocarcinoma with Ovarian Metastasis
    Wakankar, R.
    Bal, J.
    Sharma, K.
    Dougall, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S859 - S859
  • [8] Peritoneal and Nodal Gliomatosis Mimicking Metastasis on FDG PET/CT in a Patient With Ovarian Immature Teratoma
    Lee, Sang Mi
    Choi, Min Chul
    Lee, Jeong Won
    Kim, Taehoen
    Jang, Su Jin
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (08) : 707 - 709
  • [9] Isolated Splenic Metastasis of Ovarian Cancer Detected With 18F-FDG PET/CT
    Lee, Dong Hyun
    Yoon, Joon-Kee
    Lee, Su Jin
    Jo, Kyung Sook
    Yoon, Seok-Ho
    An, Young-Sil
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (04) : 349 - 351
  • [10] 18F-FDG PET/CT in Bilateral Breasts Metastasis From Ovarian Carcinoma
    Karanth, Suman S.
    Malik, Dharmender
    Khanna, Gaurav
    Sen, Ishita B.
    Manda, Divya
    Raina, Vinod
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (02) : E194 - E196